Atherosclerosis is a chronic cardiovascular disease which increases risk of major
cardiovascular events including myocardial infarction and stroke. Elevated plasma …

By 1980, it was thought that we already knew most of the major mechanisms regulating
vascular tone. However, after the somewhat serendipity discovery that endothelium is …

Background Elevated serum levels of asymmetric dimethylarginine (ADMA) are associated
with endothelial dysfunction and atherogenesis. In patients with suspected coronary artery …

Nitric oxide (NO) formed via endothelial NO synthase (eNOS) plays crucial roles in the
regulation of coronary blood flow through vasodilatation and decreased vascular resistance …

Background Pericardial fluid (PF) contains several biologically active substances, which
may provide information regarding the cardiac conditions. Nitric oxide (NO) has been …

Asymmetric dimethylarginine (ADMA) is a competitive inhibitor of the nitric oxide (NO)-
synthase and a biomarker of endothelial dysfunction (ED). ED plays an important role in the …

Objectives We measured and compared serum asymmetric dimethylarginine (ADMA),
symmetric dimethylarginine (SDMA), and L-arginine levels in patients undergoing coronary …

Objective To examine the prognostic value of serum levels of asymmetric dimethylarginine
(ADMA) in patients with stable coronary heart disease (CHD) thus explore a potential …

The methylated arginines (MAs) monomethylarginine (MMA), asymmetric dimethylarginine
(ADMA), and symmetric dimethylarginine (SDMA) have been shown to be independent …

Methylarginines (MA s) are potent vasoconstrictors that have been reported to be present at
elevated concentrations in the blood of patients suffering from cardiovascular disease. To …